CD274 and hepatocellular carcinoma: Zhang et al. [44] showed that in hepatocellular carcinoma cells, Abrine induced hepatocellular carcinoma immunity and enhanced the antitumor efficacy of immune checkpoint blockade by modulating PD-L1 signaling.